Réflexion émise en 2017 concernant les #prix astronomiques des #médicaments aux #Etats-Unis
▻https://seenthis.net/messages/634973#message634999
"Ce qui est de premier abord curieux c’est que les compagnies d’assurance, quand même « puissantes », n’opposent pratiquement pas de résistance."
Why Do Americans Pay More for Drugs ? by Robin Feldman - Project Syndicate
►https://www.project-syndicate.org/commentary/america-pharma-companies-weak-price-competition-by-robin-feldman-
At the center of the system are “pharmacy benefit managers” (PBMs), who represent health-insurance plans in drug-price negotiations with pharmaceutical companies. Because health insurers pay PBMs based on the discounts they secure, these intermediaries should in theory try to negotiate the lowest possible drug prices for their clients. But in practice, established drug companies offer PBMs financial incentives to favor their higher-priced drugs and block cheaper competitors.